Scott Wilson Curtis

This profile gathers the share dealings of Scott Wilson Curtis in Antibe Therapeutics Inc. In total, 25 filings cover trades dated from 28 March 2016 to 7 March 2024.

In open-market terms, that means 13 purchases worth €76k on one side and 4 sales worth €119k on the other. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 option exercises. Since January 2024: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €6,001. No cluster: in 10 purchases, no other insider of the company bought within 30 days.

The record was last updated on 7 March 2024 with an open-market purchase (€5,296) in Antibe Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.